Equity Details
Price & Market Data
Price: $18.19
Daily Change: +$0.03 / 0.16%
Daily Range: $17.51 - $18.37
Market Cap: $808,595,264
Daily Volume: 287,995
Performance Metrics
1 Week: 9.05%
1 Month: 12.35%
3 Months: -9.91%
6 Months: 150.6%
1 Year: 346.9%
YTD: 37.49%
About BioAge Labs, Inc. (BIOA)
Get a quick summary of BioAge Labs, Inc. (BIOA). The stock is priced at 18.19, experiencing a +$0.03 / 0.16% daily shift. Its market capitalization stands at 808,595,264. Track its performance from the last 3 months (-9.91%) to the entire year (346.9%).
Company Details
Employees: 62
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.